Oct4 expression in CSCs is associated with a more aggressive tumor phenotype (Gidekel et al., 2003; Mohiuddin et al., 2020), and in melanoma cells, it is a marker of tumor-initiating cells, metastasis, and resistance to anticancer therapies (Wang and Herlyn, 2015). This evidence concerns the gene POU5F1 and neoplasm.